Clinically Significant Proteinuria Following the Administration of Sirolimus to Renal Transplant Recipients

Publisher： Bentham Science Publishers

E-ISSN： 1874-0758|1|4|267-271

ISSN： 1872-3128

Source： Drug Metabolism Letters, Vol.1, Iss.4, 2007-12, pp. : 267-271

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Calcineurin inhibitors/mycophenolate mofetil/sirolimus: Proteinuria in renal transplant recipients: 7 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1255, 2009-01 ,pp. : 11-12

Adis International

Access to resources Recommend Favorite

Sirolimus: Proteinuria in a renal transplant recipient: case report

By  

Reactions Weekly, Vol. 1, Iss. 1099, 2006-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Immunotherapy in Elderly Transplant Recipients: A Guide to Clinically Significant Drug Interactions

By Kuypers Dirk R.J.  

Drugs & Aging, Vol. 26, Iss. 9, 2009-09 ,pp. : 715-737

Adis International

Access to resources Recommend Favorite

Sirolimus: Lung disorders in renal transplant recipients: 3 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1019, 2004-01 ,pp. : 12-13

Adis International

Access to resources Recommend Favorite

Sirolimus: Renal dysfunction in transplant recipients: 2 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1345, 2011-01 ,pp. : 28-28

Adis International

Access to resources Recommend Favorite